Skip to main content

Table 1 General clinical features

From: Effect of changing treatment to high-flux hemodialysis (HFHD) on mortality in patients with long-term low flux hemodialysis (LFHD): a propensity score matched cohort study

Groups

HFHD group

LFHD group

p

Gender (male/female)

76/38

38/19

1.000

Age (years)

50.1 ± 9.8

49.3 ± 12.7

0.055

Primary disease

 

0.836

 Chronic glomerulonephritis

33

63

 

 diabetic nephropathy

6

12

 

 Hypertensive renal damage

13

29

 

 Other diseases

5

10

 

 Dialysis age (month)

83.2 ± 30.4

79.2 ± 45.3

0.243

Laboratory examination

 Hemoglobin (g/l)

112.79 ± 15.61

112.99 ± 13.86

0.973

 Albumin (g/dl)

41.32 ± 2.05

41.35 ± 2.33

0.196

 Blood phosphorus (mmol/l)

2.16 ± 0.54

2.14 ± 0.58

0.798

 KT/V

1.35 ± 0.25

1.36 ± 0.22

0.813

 Cardiovascular complications

4

2

1.00